Sickle Cell Anemia Testing & Screening Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Sickle Cell Anemia Testing & Screening Market, By Technology

7.1.  Sickle Cell Anemia Testing & Screening Market, By Technology Type, 2020-2030

7.1.1.    Hemoglobin Electrophoresis

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    High-performance Liquid Chromatography (HPLC)

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Point-of-Care Tests

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Other Tests

7.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Sickle Cell Anemia Testing & Screening Market, By Age Group

8.1.  Sickle Cell Anemia Testing & Screening Market, By Age Group, 2020-2030

8.1.1.    Newborn Screening (12 months and below)

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Adult Screening (25 to 60 years)

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Other Age Groups (1 to 25 & above 60 years)

8.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Sickle Cell Anemia Testing & Screening Market, By Sector Type

9.1.  Sickle Cell Anemia Testing & Screening Market, By Sector Type, 2020-2030

9.1.1.    Government Labs

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Private Labs

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Corporate Labs

9.1.3.1.        Market Revenue and Forecast (2016-2030)

9.1.4.    PPP (Public-Private-Partnerships)

9.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Sickle Cell Anemia Testing & Screening Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, By Technology (2016-2030)

10.1.2.  Market Revenue and Forecast, By Age Group (2016-2030)

10.1.3.  Market Revenue and Forecast, By Sector Type (2016-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.1.4.2.      Market Revenue and Forecast, By Age Group (2016-2030)

10.1.4.3.      Market Revenue and Forecast, By Sector Type (2016-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.1.5.2.      Market Revenue and Forecast, By Age Group (2016-2030)

10.1.5.3.      Market Revenue and Forecast, By Sector Type (2016-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, By Technology (2016-2030)

10.2.2.  Market Revenue and Forecast, By Age Group (2016-2030)

10.2.3.  Market Revenue and Forecast, By Sector Type (2016-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.2.4.2.      Market Revenue and Forecast, By Age Group (2016-2030)

10.2.4.3.      Market Revenue and Forecast, By Sector Type (2016-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.2.5.2.      Market Revenue and Forecast, By Age Group (2016-2030)

10.2.5.3.      Market Revenue and Forecast, By Sector Type (2016-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.2.6.2.      Market Revenue and Forecast, By Age Group (2016-2030)

10.2.6.3.      Market Revenue and Forecast, By Sector Type (2016-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.2.7.2.      Market Revenue and Forecast, By Age Group (2016-2030)

10.2.7.3.      Market Revenue and Forecast, By Sector Type (2016-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, By Technology (2016-2030)

10.3.2.  Market Revenue and Forecast, By Age Group (2016-2030)

10.3.3.  Market Revenue and Forecast, By Sector Type (2016-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.3.4.2.      Market Revenue and Forecast, By Age Group (2016-2030)

10.3.4.3.      Market Revenue and Forecast, By Sector Type (2016-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.3.5.2.      Market Revenue and Forecast, By Age Group (2016-2030)

10.3.5.3.      Market Revenue and Forecast, By Sector Type (2016-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.3.6.2.      Market Revenue and Forecast, By Age Group (2016-2030)

10.3.6.3.      Market Revenue and Forecast, By Sector Type (2016-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.3.7.2.      Market Revenue and Forecast, By Age Group (2016-2030)

10.3.7.3.      Market Revenue and Forecast, By Sector Type (2016-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, By Technology (2016-2030)

10.4.2.  Market Revenue and Forecast, By Age Group (2016-2030)

10.4.3.  Market Revenue and Forecast, By Sector Type (2016-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.4.4.2.      Market Revenue and Forecast, By Age Group (2016-2030)

10.4.4.3.      Market Revenue and Forecast, By Sector Type (2016-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.4.5.2.      Market Revenue and Forecast, By Age Group (2016-2030)

10.4.5.3.      Market Revenue and Forecast, By Sector Type (2016-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.4.6.2.      Market Revenue and Forecast, By Age Group (2016-2030)

10.4.6.3.      Market Revenue and Forecast, By Sector Type (2016-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.4.7.2.      Market Revenue and Forecast, By Age Group (2016-2030)

10.4.7.3.      Market Revenue and Forecast, By Sector Type (2016-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, By Technology (2016-2030)

10.5.2.  Market Revenue and Forecast, By Age Group (2016-2030)

10.5.3.  Market Revenue and Forecast, By Sector Type (2016-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.5.4.2.      Market Revenue and Forecast, By Age Group (2016-2030)

10.5.4.3.      Market Revenue and Forecast, By Sector Type (2016-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, By Technology (2016-2030)

10.5.5.2.      Market Revenue and Forecast, By Age Group (2016-2030)

10.5.5.3.      Market Revenue and Forecast, By Sector Type (2016-2030)

Chapter 11.  Company Profiles

11.1.              STRECK, INC.

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Daktari Diagnostics

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              BIOMEDOMICS INC.

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Laboratory Corporation of America Holdings

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Request A Test, Ltd.

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              HALCYON BIOMEDICAL INCORPORATED

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Silver Lake Research Corporation

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              HEMOTYPE

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              HEMEX HEALTH

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           Bio-Rad Laboratories, Inc.

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

11.11.           PerkinElmer Inc.

11.11.1.               Company Overview

11.11.2.               Product Offerings

11.11.3.               Financial Performance

11.11.4.               Recent Initiatives

11.12.           Quest Diagnostics

11.12.1.               Company Overview

11.12.2.               Product Offerings

11.12.3.               Financial Performance

11.12.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

Glossary of Terms

Report Details

  • Report Code:35145
  • Category:Healthcare
  • No. of Pages:250
  • Format:PDF/PPT/Excel
  • Published:November 2020
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers